Categories
Events Funding News

Shark Tank Awards Two Researchers

Congratulations to the Winners of the McGraw Family Opioid Awards!

[vc_empty_space]

1st Place: $50,000

Christopher Connor, MD, PhD

Assistant Professor, Anesthesiology

Project: Imaging opioid effects, tolerance and addition in C. elegans

 

2nd Place: $25,000

William Renthal, MD, PhD

Assistant Professor, Neurology

Project: Targeted gene therapy for Chronic Pain

[vc_empty_space]

Featured Image:

Top Left: Scott Weiner, MD, MPH

Top Right: Captain Robert McGraw

Bottom Left: William Renthal, MD, PhD

Bottom Right: Christopher Connor, MD, PhD

[vc_empty_space]

Background on the Event:

Since 2012, Brigham & Women’s Hospital has been hosting shark tanks to fund innovative and high-risk/high impact projects in the basic, clinical, digital and translational realms through its Health & Technology Innovation Awards. Sponsored by the Brigham Research Institute (BRI) and the BWH Health & Technology Subcommittee, these awards aim to advance projects that have the potential to make an impact in one or more of the following domains – biomedical research, healthcare delivery, the generation of new companies/products/services, cost savings, care quality and provider burnout. Since 2012, more than $1 million has been distributed to BWH investigators through these awards.

This year, with the generous support of the McGraw Family, this cycle’s Request for Applications includes a special track focused on advancing innovations related to solving the opioid crisis which has resulted in the loss of over 2000 lives in the past year in Massachusetts alone. Novel ideas that seek to address questions and challenges related to the opioid epidemic including, but not limited to, research on addiction, adverse effects, alternate pain management strategies, genetic susceptibility to opioid abuse, new tools for opioid research, diagnosis/treatment, management of infectious diseases related to opioid abuse, withdrawal, personalized medicine were awarded.

[vc_empty_space]

 

Categories
Events Funding News

McGraw Opioid Innovator Award | Shark Tank Fall 2020

You’re Invited:

[vc_empty_space]

Tuesday, October 20, 4:00 – 5:30pm, Zoom

Click Here to Register

[vc_empty_space]

Since 2012, Brigham & Women’s Hospital has been hosting shark tanks to fund innovative and high-risk/high impact projects in the basic, clinical, digital and translational realms through its Health & Technology Innovation Awards. Sponsored by the Brigham Research Institute (BRI) and the BWH Health & Technology Subcommittee, these awards aim to advance projects that have the potential to make an impact in one or more of the following domains – biomedical research, healthcare delivery, the generation of new companies/products/services, cost savings, care quality and provider burnout. Since 2012, more than $1 million has been distributed to BWH investigators through these awards.

This year, with the generous support of the McGraw Family, this cycle’s Request for Applications includes a special track focused on advancing innovations related to solving the opioid crisis which has resulted in the loss of over 2000 lives in the past year in Massachusetts alone. Novel ideas that seek to address questions and challenges related to the opioid epidemic including, but not limited to, research on addiction, adverse effects, alternate pain management strategies, genetic susceptibility to opioid abuse, new tools for opioid research, diagnosis/treatment, management of infectious diseases related to opioid abuse, withdrawal, personalized medicine will be awarded.

Please note that this event is exclusively for Brigham and Women’s Hospital Staff and Mass General Brigham affiliates.

For more information, please contact bwhbri@partners.org

[vc_empty_space]

 

Categories
Events Funding News

McGraw Family Opioid Innovator Awards | Fall 2020

We are excited to announce that Brigham & Women’s Hospital will host a Shark Tank event in Oct 2020 to fund two innovative and high-risk/high- impact projects in the basic, clinical, digital and translational realms through the McGraw Family Innovator Awards (open to opioid-related research).

Letter of Intent Due: Wednesday, July 22, 2020 | Click here to apply

RFA Due: Friday, September 11, 2020 | Click here for RFA details

[vc_empty_space]
Scope: With the generous support of the McGraw Family, this year’s RFA will focus on advancing innovations related to solving the opioid crisis which has resulted in the loss of over 2000 lives a year for the past 3 years in Massachusetts alone. Novel ideas that seek to address questions and challenges related to the opioid epidemic including but not limited to research on addiction, adverse effects, alternate pain management strategies, genetic susceptibility to opioid abuse, new tools for opioid research, diagnosis/treatment, management of infectious diseases related to opioid abuse, withdrawal, personalized medicine etc. are welcome. Special focus on COVID-19 related research and racial and ethnic disparities research is also welcome.
[vc_empty_space]

Awards: Up to two non-renewable grants will be awarded on a competitive basis with award denominations of up to $50,000 and $25,000 respectively.

[vc_empty_space]
For more information, please contact:
Gloria Brand, MPA, Senior Program Manager
Program in Opioid and Pain Innovation
BWH
617-278-0516
gbrand@bwh.harvard.edu
Categories
Funding News

Systems Immunology Pilot Project Grants

 Deadline: August 10, 2018

 

The goal of this pilot grant program is to develop innovative assays that can be deployed in our CRISPR platform to identify novel regulators of immune responses to acute infection and/or to develop computational approaches for analyzing single cell data. These grants will provide support for generating preliminary data for future applications for independent research support.

 

Goals:

  • Stimulate innovation in two main areas:

New and innovative assays that could be deployed in an in vivo or in vitro CRISPR screening platform to understand innate and adaptive immune responses triggered by pathogens, adjuvants, or vaccines. These might include new methodologies or cell phenotypes for screens.

The development of new tools, reagents, and computational methods to generate better single cell data and to analyze the data arising from the U19 projects.

  • Support research initiated by early career investigators

 

ELIGIBLITY

Any faculty member who holds an appointment at Harvard University as an assistant professor, associate professor, or professor, irrespective of type of degree or institutional affiliation, is eligible to be the PI.  Faculty members at MIT who hold appointments as assistant professors, associate professors, or professors are also eligible. Please see the RFA and FAQs for more information.

Applicants may submit proposals with requests for up to $75,000. 

 

QUESTIONS?

If you have questions, please contact us.

Please see the website for complete information.